Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1969 5
1970 6
1971 7
1972 3
1973 2
1974 7
1975 9
1976 6
1977 7
1978 8
1979 10
1980 19
1981 15
1982 12
1983 13
1984 31
1985 26
1986 27
1987 36
1988 26
1989 26
1990 21
1991 19
1992 22
1993 35
1994 40
1995 33
1996 46
1997 32
1998 34
1999 22
2000 32
2001 24
2002 28
2003 26
2004 12
2005 15
2006 16
2007 27
2008 24
2009 15
2010 16
2011 14
2012 13
2013 15
2014 4
2015 4
2016 1
2017 8
2018 7
2019 2
2020 5
2021 8
2022 8
2023 2
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

905 results

Results by year

Filters applied: . Clear all
Page 1
European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.
Baccarani M, Deininger MW, Rosti G, Hochhaus A, Soverini S, Apperley JF, Cervantes F, Clark RE, Cortes JE, Guilhot F, Hjorth-Hansen H, Hughes TP, Kantarjian HM, Kim DW, Larson RA, Lipton JH, Mahon FX, Martinelli G, Mayer J, Müller MC, Niederwieser D, Pane F, Radich JP, Rousselot P, Saglio G, Saußele S, Schiffer C, Silver R, Simonsson B, Steegmann JL, Goldman JM, Hehlmann R. Baccarani M, et al. Among authors: goldman jm. Blood. 2013 Aug 8;122(6):872-84. doi: 10.1182/blood-2013-05-501569. Epub 2013 Jun 26. Blood. 2013. PMID: 23803709 Free PMC article. Review.
A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias.
Cortes JE, Kim DW, Pinilla-Ibarz J, le Coutre P, Paquette R, Chuah C, Nicolini FE, Apperley JF, Khoury HJ, Talpaz M, DiPersio J, DeAngelo DJ, Abruzzese E, Rea D, Baccarani M, Müller MC, Gambacorti-Passerini C, Wong S, Lustgarten S, Rivera VM, Clackson T, Turner CD, Haluska FG, Guilhot F, Deininger MW, Hochhaus A, Hughes T, Goldman JM, Shah NP, Kantarjian H; PACE Investigators. Cortes JE, et al. Among authors: goldman jm. N Engl J Med. 2013 Nov 7;369(19):1783-96. doi: 10.1056/NEJMoa1306494. Epub 2013 Nov 1. N Engl J Med. 2013. PMID: 24180494 Free PMC article. Clinical Trial.
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.
O'Brien SG, Guilhot F, Larson RA, Gathmann I, Baccarani M, Cervantes F, Cornelissen JJ, Fischer T, Hochhaus A, Hughes T, Lechner K, Nielsen JL, Rousselot P, Reiffers J, Saglio G, Shepherd J, Simonsson B, Gratwohl A, Goldman JM, Kantarjian H, Taylor K, Verhoef G, Bolton AE, Capdeville R, Druker BJ; IRIS Investigators. O'Brien SG, et al. Among authors: goldman jm. N Engl J Med. 2003 Mar 13;348(11):994-1004. doi: 10.1056/NEJMoa022457. N Engl J Med. 2003. PMID: 12637609 Free article. Clinical Trial.
Prolymphocytic leukaemia.
Galton DA, Goldman JM, Wiltshaw E, Catovsky D, Henry K, Goldenberg GJ. Galton DA, et al. Among authors: goldman jm. Br J Haematol. 1974 May;27(1):7-23. doi: 10.1111/j.1365-2141.1974.tb06769.x. Br J Haematol. 1974. PMID: 4137136 No abstract available.
Current pre-clinical and clinical advances in the BCR-ABL1-positive and -negative chronic myeloproliferative neoplasms.
Mughal TI, Vannucchi AM, Soverini S, Bazeos A, Tibes R, Saglio G, Abdel-Wahab O, Pardanani A, Hehlmann R, Barbui T, Van Etten R, Tefferi A, Goldman JM. Mughal TI, et al. Among authors: goldman jm. Haematologica. 2014 May;99(5):797-801. doi: 10.3324/haematol.2013.097832. Haematologica. 2014. PMID: 24790057 Free PMC article. Review. No abstract available.
Acute promyelocytic leukaemia.
Goldman JM. Goldman JM. Br Med J. 1974 Mar 2;1(5904):380-2. doi: 10.1136/bmj.1.5904.380. Br Med J. 1974. PMID: 4522493 Free PMC article.
What challenges remain in chronic myeloid leukemia research?
Carella AM, Branford S, Deininger M, Mahon FX, Saglio G, Eiring A, Khorashad J, O'Hare T, Goldman JM. Carella AM, et al. Among authors: goldman jm. Haematologica. 2013 Aug;98(8):1168-72. doi: 10.3324/haematol.2013.090381. Haematologica. 2013. PMID: 23904234 Free PMC article. No abstract available.
Advances in CML.
Goldman JM. Goldman JM. Clin Adv Hematol Oncol. 2007 Apr;5(4):270-2, 292. Clin Adv Hematol Oncol. 2007. PMID: 17607286 Review. No abstract available.
The heterogeneity and diversity of hypertension in CKD.
Goldman JM, Cohen DL, Sim JJ. Goldman JM, et al. Adv Chronic Kidney Dis. 2015 Mar;22(2):86-7. doi: 10.1053/j.ackd.2014.12.003. Adv Chronic Kidney Dis. 2015. PMID: 25704343 No abstract available.
Bone marrow transplantation for CML.
Mackinnon S, Goldman JM. Mackinnon S, et al. Among authors: goldman jm. Baillieres Clin Haematol. 1987 Dec;1(4):1055-76. doi: 10.1016/s0950-3536(87)80039-2. Baillieres Clin Haematol. 1987. PMID: 3332853 Review. No abstract available.
905 results